BridgeBio Pharma, Inc. (BBIO) Revenue 2019–2025
BridgeBio Pharma, Inc. (BBIO) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$502.1MFY2025 · since FY2019: $40.6M → $502.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $502.1M | +126.3% |
| FY2024 | $221.9M | +2285.3% |
| FY2023 | $9.3M | -88.0% |
| FY2022 | $77.6M | +11.4% |
| FY2021 | $69.7M | +745.1% |
| FY2020 | $8.2M | -79.7% |
| FY2019 | $40.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice